← All stories
Markets
Trump inks deal with 9 pharmaceutical companies to lower drug costs
The White House said the agreements will reduce costs to treat Parkinson's disease, macular degeneration, glaucoma, liver disease and other illnesses.
Covered by 1 outlet
All coverage · 1 article